This study was undertaken to observe whether EA would affect the expression of P450arom and P450c17α and their mRNA expression in PCOS ovarian tissues using letrozole, a non-steroidal aromatase inhibitor, as a reference for preparing a PCOS animal model (similar to that of Kafali [15]). Here, CYP19A1 is linked to polycystic ovary syndrome.